Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Foghorn Therapeutics Inc.

Initiate IND application for Selective CBP Degrader

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
3 Feb 2025
Due
30 Jun 2026
Checked
18 Sep 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Selective CBP Degrader IND expected H1 2026”

What we found

Evidence strength D What the grades mean

Foghorn repeatedly pushed back its Selective CBP Degrader IND timeline from H1 2026 to 2027, then withdrew that 2027 guidance in August 2026 due to a CRO issue.

Checked 18 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory other
Indicative materiality
Medium rules
Action
Initiate
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
  3. Second checkThe evidence document could not be read for a second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Foghorn Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-FHTX-000109 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.